Related Experiment Video
Updated: May 12, 2026

A Microscopic 2,3,5-Triphenyltetrazolium Chloride Assay for Accurate and Reliable Analysis of Myocardial Injury
Published on: November 28, 2025
Time-dependent degradation pattern of cardiac troponin T following myocardial infarction
Eline P M Cardinaels1, Alma M A Mingels, Tom van Rooij
1Department of Clinical Chemistry, Maastricht University Medical Center, the Netherlands. mp.van.dieijen.visser@mumc.nl
Insights
Degraded cardiac troponin T (cTnT) forms are detected in acute myocardial infarction (AMI) patients
Area of Science:
- Biochemistry
- Clinical Chemistry
- Cardiology
Background:
- Cardiac troponin T (cTnT) is a critical biomarker for diagnosing acute myocardial infarction (AMI).
- The presence and detection of degraded cTnT forms in patient blood remain unclear.
- Understanding cTnT forms is essential for accurate diagnostic assays.
Purpose of the Study:
- To identify and characterize the different forms of cTnT circulating in AMI patients' sera.
- To determine which cTnT forms are recognized by the clinical immunoassay.
Main Methods:
- Serum samples from 13 AMI patients were analyzed using gel filtration chromatography (GFC) to separate cTnT forms.
- Western blot analysis with antibodies from the Roche immunoassay was performed on GFC eluates.
- Time-dependent degradation patterns were assessed using Western blot on serum samples from 18 AMI patients collected over 72 hours.
Main Results:
- GFC revealed two distinct cTnT peaks, corresponding to fragments of approximately 29 kDa and 14-18 kDa.
- Western blot analysis confirmed the presence of these fragments and indicated a time-dependent degradation of cTnT.
- Intact cTnT (40 kDa) was detected in only a small subset of patients within the first 8 hours post-admission.
Conclusions:
- The Roche cTnT immunoassay detects both intact and degraded forms of cTnT in AMI patients' sera.
- cTnT undergoes time-dependent degradation following acute myocardial infarction.
- These findings highlight the importance of considering cTnT degradation in diagnostic interpretations.
Background:
Cardiac troponin T (cTnT) is widely used for the diagnosis of acute myocardial infarction (AMI). However, it is still unclear whether degraded cTnT forms circulate in the patient's blood. We therefore aimed to elucidate which cTnT forms are detected by the clinical assay.
Methods:
Separation of cTnT forms by gel filtration chromatography (GFC) was performed in sera from 13 AMI patients to examine cTnT degradation. The GFC eluates were subjected to Western blot analysis with the original antibodies from the Roche immunoassay used to mimic the clinical cTnT assay. To investigate the degradation pattern with time, standardized serum samples of 18 AMI patients collected 0-72 h after admission were analyzed by Western blot analysis.
Results:
GFC analysis of AMI patients' sera revealed 2 cTnT peaks with retention volumes of 5 and 21 mL. Western blot analysis identified these peaks as cTnT fragments of 29 and 14-18 kDa, respectively. Furthermore, the performance of direct Western blots on standardized serum samples demonstrated a time-dependent degradation pattern of cTnT, with fragments ranging between 14 and 40 kDa. Intact cTnT (40 kDa) was present in only 3 patients within the first 8 h after hospital admission.
Conclusions:
These results demonstrate that the Roche cTnT immunoassay detects intact as well as degraded cTnT forms in AMI patients' sera during the period of diagnostic testing. Moreover, following AMI, cTnT is degraded in a time-dependent pattern.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Myocarditis I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Transient Ischemic Attack l: Introduction
